A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder

Alicia Diaz-Thomas, John Cannon, Pallavi Iyer, Almundher Al-Maawali, Mohammed Fazalullah, Frank Diamond, O. Thomas Mueller, Allen W. Root, Saif Alyaarubi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Neonatal severe primary hyperparathyroidism (NSHPT, MIM 239200) is most often an isolated disorder that is due to biallelic inactivating mutations in the CASR, the gene encoding the calcium sensing receptor; NSHPT is inherited from parents with familial hypocalciuric hypercalcemia, each of whom has one mutated CASR allele. Objectives: To report clinical and genetic findings in a brother and sister with NSHPT due to a novel mutation in the CASR transmitted as an autosomal recessive trait and to examine the functional effect of the mutation. Subjects and methods: A brother and sister with marked hypercalcemia due to NSHPT were identified; the boy also had craniosynostosis requiring surgical repair. The genotyping of the CASR in both children and their parents who were eucalcemic and normophosphatemic was undertaken. In order to examine the significance of the variant CASR identified, the CASR variant was expressed in vitro and examined by three computer computational programs [PolyPhen2, MutationTaster, Sorting Intolerant From Tolerant (SIFT)] designed to evaluate the effect of a nucleotide variant on the structure and likely functional consequence upon the protein product. Results: A sequence variant in the CASR was identified [G>T point mutation at nucleotide c.2303 in exon 7 (c.2303G>T) resulting in the replacement of glycine by valine at codon 768 (p.Gly768Val)]. Two copies of this CASR variant were present in the genome of the siblings while a single copy of the CASR variant was present in both of the clinically and biochemically normal parents, a pattern of transmission consistent with autosomal recessive inheritance of NSHPT in this family. When expressed in HEK293 cells in vitro, the novel Gly768Val variant did not interfere with protein generation or migration to the cell membrane in vitro. The analysis of the functional effect of the Gly768Val CASR variant by the PolyPhen2, MutationTaster, and Sorting Intolerant From Tolerant computer programs revealed that this mutation was very likely to be deleterious. Conclusion: The NSHPT associated with biallelic Gly768Val mutations of the CASR in two siblings with severe hypercalcemia and hyperparathyroidism and their clinically and biochemically normal heterozygous parents was transmitted as an autosomal recessive disorder in this family.

Original languageEnglish
Pages (from-to)851-856
Number of pages6
JournalJournal of Pediatric Endocrinology and Metabolism
Volume27
Issue number9-10
DOIs
Publication statusPublished - Sep 20 2014

Fingerprint

Hyperparathyroidism
Siblings
Mutation
Parents
Hypercalcemia
Software
Nucleotides
Calcium-Sensing Receptors
Craniosynostoses
HEK293 Cells
Valine
Point Mutation
Codon
Glycine
Exons
Proteins
Alleles
Cell Membrane
Genome
Genes

Keywords

  • calcium sensing receptor (CaSR)
  • familial/hereditary hypocalciuric hypercalcemia
  • neonatal hypercalcemia
  • neonatal severe hyperparathyroidism

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder. / Diaz-Thomas, Alicia; Cannon, John; Iyer, Pallavi; Al-Maawali, Almundher; Fazalullah, Mohammed; Diamond, Frank; Mueller, O. Thomas; Root, Allen W.; Alyaarubi, Saif.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 27, No. 9-10, 20.09.2014, p. 851-856.

Research output: Contribution to journalArticle

Diaz-Thomas, Alicia ; Cannon, John ; Iyer, Pallavi ; Al-Maawali, Almundher ; Fazalullah, Mohammed ; Diamond, Frank ; Mueller, O. Thomas ; Root, Allen W. ; Alyaarubi, Saif. / A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder. In: Journal of Pediatric Endocrinology and Metabolism. 2014 ; Vol. 27, No. 9-10. pp. 851-856.
@article{404a45a05a8549d3b7bde31a3639cafd,
title = "A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder",
abstract = "Background: Neonatal severe primary hyperparathyroidism (NSHPT, MIM 239200) is most often an isolated disorder that is due to biallelic inactivating mutations in the CASR, the gene encoding the calcium sensing receptor; NSHPT is inherited from parents with familial hypocalciuric hypercalcemia, each of whom has one mutated CASR allele. Objectives: To report clinical and genetic findings in a brother and sister with NSHPT due to a novel mutation in the CASR transmitted as an autosomal recessive trait and to examine the functional effect of the mutation. Subjects and methods: A brother and sister with marked hypercalcemia due to NSHPT were identified; the boy also had craniosynostosis requiring surgical repair. The genotyping of the CASR in both children and their parents who were eucalcemic and normophosphatemic was undertaken. In order to examine the significance of the variant CASR identified, the CASR variant was expressed in vitro and examined by three computer computational programs [PolyPhen2, MutationTaster, Sorting Intolerant From Tolerant (SIFT)] designed to evaluate the effect of a nucleotide variant on the structure and likely functional consequence upon the protein product. Results: A sequence variant in the CASR was identified [G>T point mutation at nucleotide c.2303 in exon 7 (c.2303G>T) resulting in the replacement of glycine by valine at codon 768 (p.Gly768Val)]. Two copies of this CASR variant were present in the genome of the siblings while a single copy of the CASR variant was present in both of the clinically and biochemically normal parents, a pattern of transmission consistent with autosomal recessive inheritance of NSHPT in this family. When expressed in HEK293 cells in vitro, the novel Gly768Val variant did not interfere with protein generation or migration to the cell membrane in vitro. The analysis of the functional effect of the Gly768Val CASR variant by the PolyPhen2, MutationTaster, and Sorting Intolerant From Tolerant computer programs revealed that this mutation was very likely to be deleterious. Conclusion: The NSHPT associated with biallelic Gly768Val mutations of the CASR in two siblings with severe hypercalcemia and hyperparathyroidism and their clinically and biochemically normal heterozygous parents was transmitted as an autosomal recessive disorder in this family.",
keywords = "calcium sensing receptor (CaSR), familial/hereditary hypocalciuric hypercalcemia, neonatal hypercalcemia, neonatal severe hyperparathyroidism",
author = "Alicia Diaz-Thomas and John Cannon and Pallavi Iyer and Almundher Al-Maawali and Mohammed Fazalullah and Frank Diamond and Mueller, {O. Thomas} and Root, {Allen W.} and Saif Alyaarubi",
year = "2014",
month = "9",
day = "20",
doi = "10.1515/jpem-2013-0343",
language = "English",
volume = "27",
pages = "851--856",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "9-10",

}

TY - JOUR

T1 - A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder

AU - Diaz-Thomas, Alicia

AU - Cannon, John

AU - Iyer, Pallavi

AU - Al-Maawali, Almundher

AU - Fazalullah, Mohammed

AU - Diamond, Frank

AU - Mueller, O. Thomas

AU - Root, Allen W.

AU - Alyaarubi, Saif

PY - 2014/9/20

Y1 - 2014/9/20

N2 - Background: Neonatal severe primary hyperparathyroidism (NSHPT, MIM 239200) is most often an isolated disorder that is due to biallelic inactivating mutations in the CASR, the gene encoding the calcium sensing receptor; NSHPT is inherited from parents with familial hypocalciuric hypercalcemia, each of whom has one mutated CASR allele. Objectives: To report clinical and genetic findings in a brother and sister with NSHPT due to a novel mutation in the CASR transmitted as an autosomal recessive trait and to examine the functional effect of the mutation. Subjects and methods: A brother and sister with marked hypercalcemia due to NSHPT were identified; the boy also had craniosynostosis requiring surgical repair. The genotyping of the CASR in both children and their parents who were eucalcemic and normophosphatemic was undertaken. In order to examine the significance of the variant CASR identified, the CASR variant was expressed in vitro and examined by three computer computational programs [PolyPhen2, MutationTaster, Sorting Intolerant From Tolerant (SIFT)] designed to evaluate the effect of a nucleotide variant on the structure and likely functional consequence upon the protein product. Results: A sequence variant in the CASR was identified [G>T point mutation at nucleotide c.2303 in exon 7 (c.2303G>T) resulting in the replacement of glycine by valine at codon 768 (p.Gly768Val)]. Two copies of this CASR variant were present in the genome of the siblings while a single copy of the CASR variant was present in both of the clinically and biochemically normal parents, a pattern of transmission consistent with autosomal recessive inheritance of NSHPT in this family. When expressed in HEK293 cells in vitro, the novel Gly768Val variant did not interfere with protein generation or migration to the cell membrane in vitro. The analysis of the functional effect of the Gly768Val CASR variant by the PolyPhen2, MutationTaster, and Sorting Intolerant From Tolerant computer programs revealed that this mutation was very likely to be deleterious. Conclusion: The NSHPT associated with biallelic Gly768Val mutations of the CASR in two siblings with severe hypercalcemia and hyperparathyroidism and their clinically and biochemically normal heterozygous parents was transmitted as an autosomal recessive disorder in this family.

AB - Background: Neonatal severe primary hyperparathyroidism (NSHPT, MIM 239200) is most often an isolated disorder that is due to biallelic inactivating mutations in the CASR, the gene encoding the calcium sensing receptor; NSHPT is inherited from parents with familial hypocalciuric hypercalcemia, each of whom has one mutated CASR allele. Objectives: To report clinical and genetic findings in a brother and sister with NSHPT due to a novel mutation in the CASR transmitted as an autosomal recessive trait and to examine the functional effect of the mutation. Subjects and methods: A brother and sister with marked hypercalcemia due to NSHPT were identified; the boy also had craniosynostosis requiring surgical repair. The genotyping of the CASR in both children and their parents who were eucalcemic and normophosphatemic was undertaken. In order to examine the significance of the variant CASR identified, the CASR variant was expressed in vitro and examined by three computer computational programs [PolyPhen2, MutationTaster, Sorting Intolerant From Tolerant (SIFT)] designed to evaluate the effect of a nucleotide variant on the structure and likely functional consequence upon the protein product. Results: A sequence variant in the CASR was identified [G>T point mutation at nucleotide c.2303 in exon 7 (c.2303G>T) resulting in the replacement of glycine by valine at codon 768 (p.Gly768Val)]. Two copies of this CASR variant were present in the genome of the siblings while a single copy of the CASR variant was present in both of the clinically and biochemically normal parents, a pattern of transmission consistent with autosomal recessive inheritance of NSHPT in this family. When expressed in HEK293 cells in vitro, the novel Gly768Val variant did not interfere with protein generation or migration to the cell membrane in vitro. The analysis of the functional effect of the Gly768Val CASR variant by the PolyPhen2, MutationTaster, and Sorting Intolerant From Tolerant computer programs revealed that this mutation was very likely to be deleterious. Conclusion: The NSHPT associated with biallelic Gly768Val mutations of the CASR in two siblings with severe hypercalcemia and hyperparathyroidism and their clinically and biochemically normal heterozygous parents was transmitted as an autosomal recessive disorder in this family.

KW - calcium sensing receptor (CaSR)

KW - familial/hereditary hypocalciuric hypercalcemia

KW - neonatal hypercalcemia

KW - neonatal severe hyperparathyroidism

UR - http://www.scopus.com/inward/record.url?scp=84906974113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906974113&partnerID=8YFLogxK

U2 - 10.1515/jpem-2013-0343

DO - 10.1515/jpem-2013-0343

M3 - Article

VL - 27

SP - 851

EP - 856

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - 9-10

ER -